국가: 캐나다
언어: 영어
출처: Health Canada
MINERAL OIL LIGHT
GLAXOSMITHKLINE INC
D02AC
SOFT PARAFFIN AND FAT PRODUCTS
63.4%
LIQUID
MINERAL OIL LIGHT 63.4%
TOPICAL
250ML
OTC
BASIC OINTMENTS AND PROTECTANTS
Active ingredient group (AIG) number: 0126693003; AHFS:
CANCELLED POST MARKET
2017-02-28
_2013-08-01/131-pristine-english-Oilatum.doc _ _ _ _ _ _ _ _ Page 1 of 5_ _ _ _ _ PRESCRIBING INFORMATION OILATUM ® Light Liquid Paraffin (LLP), 63.40% w/w DERMATOLOGICAL SHOWER AND BATH OIL GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4 www.stiefel.ca Date of Revision: May 7, 2013 Submission Control No: 161615 _©_ _ 2013 GlaxoSmithKline Inc. All Rights Reserved_ ® _ OILATUM is under license by GlaxoSmithKline Inc. _ _2013-08-01/131-pristine-english-Oilatum.doc _ _ _ _ _ _ _ _ Page 2 of 5_ _ _ _ _ OILATUM ® Light Liquid Paraffin (LLP), 63.40% w/w THERAPEUTIC CLASSIFICATION Dermatologicals, other emollients and protectives INDICATIONS AND CLINICAL USE OILATUM ® (Light Liquid Paraffin (LLP), 63.40% w/w) relieves dry, itchy, sensitive skin, softens and hydrates the skin and helps protect against further drying. CONTRAINDICATIONS No contraindications identified. WARNINGS AND PRECAUTIONS OILATUM ® should be used with caution in patients with a known sensitivity to LLP or to any of the excipients in the preparation. OILATUM ® is for external use only. Patients should be advised to avoid contact with the eyes. If contact occurs, rinse with water. If skin irritation occurs, patients should discontinue use. Patients should be advised to consult a healthcare practitioner of symptoms worsen or last for more than 7 days. SEXUAL FUNCTION/REPRODUCTION There are no data on the use of cutaneous LLP on human fertility. SPECIAL POPULATIONS PREGNANT WOMEN: No effects during pregnancy are anticipated, since systemic exposure to LLP is expected to be low _2013-08-01/131-pristine-english-Oilatum.doc _ _ _ _ _ _ _ _ Page 3 of 5_ _ _ _ _ NURSING WOMEN: It is not known if LLP is excreted in human milk. Risk to the infant is likely to be low since systemic exposure is low. Patients should be advised to ensure that any residual product is fully washed off the breast prior to breast-feeding. ADVERSE REACTIONS Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequen 전체 문서 읽기